Amicus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	214.01	213.75	246.99	148.81	245.2
Short-Term Investments	79.53	36.19	39.21	144.78	237.3
Cash & Short-Term Investments	293.54	249.95	286.2	293.6	482.5
Cash Growth	17.44%	-12.67%	-2.52%	-39.15%	-0.16%
Receivables	115.31	101.1	87.63	66.2	52.67
Inventory	228.82	118.78	59.7	23.82	26.82
Prepaid Expenses	38.51	34.91	49.53	40.21	34.85
Total Current Assets	676.17	504.74	483.06	423.82	596.83
Property, Plant & Equipment	48.25	51.66	57.98	60.31	63.08
Goodwill	197.8	197.8	197.8	197.8	197.8
Other Intangible Assets	13.92	17.2	20.49	23	-
Long-Term Deferred Charges	-	-	-	-	23
Other Long-Term Assets	13.74	13.64	18.55	19.24	24.43
Total Assets	949.87	785.03	777.88	724.17	905.14
Accounts Payable	28.63	12.95	15.12	15.41	21.51
Accrued Expenses	159.97	96.7	121.44	80.23	87.8
Current Portion of Leases	8.74	8.46	8.32	8.55	7.41
Current Income Taxes Payable	28.81	18.11	12.43	5.94	6.15
Other Current Liabilities	11.68	12.49	10.37	28.88	23.1
Total Current Liabilities	237.83	148.7	167.69	139.02	145.98
Long-Term Debt	392.66	390.11	387.86	391.99	389.36
Long-Term Leases	40.96	45.08	48.88	51.58	43.36
Long-Term Unearned Revenue	-	-	-	-	5.91
Long-Term Deferred Tax Liabilities	-	-	-	-	4.93
Other Long-Term Liabilities	4.18	7.1	13.28	18.53	8.24
Total Liabilities	675.63	590.99	617.71	601.12	597.77
Common Stock	3.04	2.94	2.92	2.82	2.81
Additional Paid-In Capital	3,014	2,926	2,836	2,665	2,595
Retained Earnings	-2,767	-2,740	-2,684	-2,532	-2,296
Treasury Stock	-0.07	-	-	-	-
Comprehensive Income & Other	24.11	5.17	5.31	-12.02	5.06
Shareholders' Equity	274.24	194.05	160.17	123.05	307.37
Total Liabilities & Equity	949.87	785.03	777.88	724.17	905.14
Total Debt	442.36	443.64	445.06	452.12	440.13
Net Cash (Debt)	-148.83	-193.7	-158.86	-158.53	42.37
Net Cash Growth	-	-	-	-	1.99%
Net Cash Per Share	-0.48	-0.64	-0.54	-0.55	0.16
Filing Date Shares Outstanding	314	300.12	295.38	282.71	280.03
Total Common Shares Outstanding	310.85	299.04	293.59	281.11	278.91
Working Capital	438.35	356.03	315.37	284.8	450.86
Book Value Per Share	0.88	0.65	0.55	0.44	1.10
Tangible Book Value	62.53	-20.95	-58.11	-97.75	109.57
Tangible Book Value Per Share	0.20	-0.07	-0.20	-0.35	0.39
Land	-	-	-	-	3.19
Machinery	25.28	25.13	24.15	23.63	25.62
Construction In Progress	-	0.26	3.81	4.16	8.23
Leasehold Improvements	33.07	32.36	28.03	24.16	24.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.